🇪🇺 Vimpat in European Union

Vimpat (lacosamide) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/000863
  • Local brand name: Vimpat
  • Status: approved

Vimpat in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in European Union

Frequently asked questions

Is Vimpat approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Vimpat in European Union?

UCB is the originator. The local marketing authorisation holder may differ — check the official source linked above.